Study to Assess the Safety, Pharmacokinetics/Dynamics of DS-1040b in Subjects With Acute Submassive Pulmonary Embolism

NCT02923115 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

134

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Embolism
Thrombotic Disease

Interventions

DRUG: DS-1040b
DRUG: Placebo
DRUG: Enoxaparin

Sponsor

Daiichi Sankyo